Tag: Stock Market

JM Financial Read More | Source: The Hindu Business Line…

Benchmark indices slip 2.9% comared to bigger fall of global indices Read More | Source: The Hindu Business Line…

Kairosoft AI Solutions moves Delhi High Court challenging BSE for keeping its stock under GSM Stage-4 Read More | Source: The Hindu Business Line…

The BSE Sensex soared 1.77% or 1,310.11 points to close at 75,157.26, while the NSE Nifty 50 climbed 1.92% or 429.40 points to end at 22,828.55 Read More | Source: The Hindu Business Line…

Policymakers urged to allow Indian companies with a primary listing on NSE and/or BSE to obtain a secondary listing on the LSE and vice versa Read More | Source: The Hindu Business Line…

Market breadth was overwhelmingly positive, with 3,115 stocks advancing against 846 declining on the BSE Read More | Source: The Hindu Business Line…

SIP contribution down to a 4-month low Read More | Source: The Hindu Business Line…

The company announced that deliveries will commence across India later this month Read More | Source: The Hindu Business Line…

Brokerage Indsec projects HZL’s revenue, EBITDA and PAT to grow at a CAGR of 9.7 per cent, 13 per cent and 16 per cent respectively over FY24-27 period Read More | Source: The Hindu Business Line…

KP Mohanakrishnan takes over as Deputy CEO & President – Aerospace and D Murali Krishnan as Chief Operating Officer & President – ESAI Read More | Source: The Hindu Business Line…

The renewed agreement will see Infosys leverage its expertise in agile practices and AI-powered tools to help AIB enhance operational efficiency and expedite innovation across its banking platforms Read More | Source: The Hindu Business Line…

Reliance Industries, Tata Steel, Tata Motors, Adani Enterprises, Adani Green Energy, Hindalco, JSW Steel soar amid strong global cues Read More | Source: The Hindu Business Line…

Shares of Tata Steel and Tata Motors gained 5-6 per cent in early trade, leading the Nifty 50 components Read More | Source: The Hindu Business Line…

The approval was based on comprehensive comparative data showing no clinically meaningful differences between Jobevne and Avastin in terms of pharmacokinetics, safety, efficacy, and immunogenicity Read More | Source: The Hindu Business Line…

RIL clarified that the deal is a related party transaction conducted on an arm’s length basis. The company stated that none of its promoter groups or other group companies have any interest in this transaction Read More | Source: The Hindu Business Line…